ストックスクリーナーアプリを入手
0.147
4.93%
0.0069
前日終値:
$0.1401
開ける：
$0.1366
24時間の取引高:
282.46K
Relative Volume:
0.23
時価総額：
$1.63M
収益：
当期純損益:
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
1週間 パフォーマンス:
-8.07%
1か月 パフォーマンス:
-37.69%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$0.00
$0.00
1週間の範囲:
$0.1344
$0.16
52週間の値動き範囲:
$0.1344
$0.4599
Endovia Health Sciences, Inc. Stock (EDVA) Company Profile
Compare EDVA vs VRTX, MRNA, REGN, ARGX, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
EDVA
Endovia Health Sciences, Inc.
|
0.147 | 1.63M | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
508.75 | 128.95B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
236.50 | 94.42B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
796.34 | 81.99B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
846.27 | 53.22B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
374.08 | 42.32B | 5.76B | 514.49M | 1.10B | 4.4813 |
Endovia Health Sciences, Inc. (EDVA) 最新ニュース
Endovia Health Sciences Announces FDA Minor Use Determination for CannEpil® in Dogs With Bone Cancer Pain - Quiver Quantitative
A proposed treatment for dogs’ bone cancer pain qualifies to pursue conditional FDA approval - Stock Titan
Endovia Health Sciences Enters Letter Agreement With C/M Capital Master Fund On Sept 18, 2026 - TradingView
Endovia Health Sciences Secures $1 Million Investment Commitment for CannEpil Development - Minichart
Endovia Health Sciences Secures $510,000 Convertible Note From C/M Capital, Part of $1 Million Commitment - TradingView
Endovia secures $1M minimum investment commitment - Stock Titan
Form PRE 14A ENDOVIA HEALTH SCIENCES For: 24 September By Investing.com - Investing.com Nigeria
Form PRE 14A ENDOVIA HEALTH SCIENCES For: 24 September By Investing.com - Investing.com Canada
Endovia Health Sciences (EVDA) Stock Soars 48% After-Hours: Here's What's Going On - Benzinga
Endovia Health Sciences Secures Initial Funding to Advance CannEpil Development - citybiz
Endovia Health Sciences Announces Closing of Initial Funding Tranche to Advance CannEpil® Development and Commercialization - Quiver Quantitative
A proposed law could give qualifying botanical drugs 12 years of market exclusivity. Endovia closes funding. - Stock Titan
EDVA PE Ratio & Valuation, Is EDVA Overvalued - Intellectia AI
EDVA Technical Analysis & Stock Price Forecast - Intellectia AI
EDVA Should I Buy - Intellectia AI
EDVA Stock: Price, Forecast, Financials & AI Analysis - Intellectia AI
Splash Beverage H1 loss narrows 64%, rebrands as Endovia Health Sciences - scanx.trade
Endovia Health Sciences Welcomes Historic Shift in Federal - GlobeNewswire
Endovia Health Sciences Welcomes Historic Shift in Federal Cannabinoid Policy; Advances CannEpil® FDA Submission and Expands Development Pipeline - Yahoo Finance
Endovia Health Sciences, formerly Splash Beverage, Achieves First FDA Regulatory Milestone for CannEpil® Veterinary Development Program - Yahoo Finance
Endovia Health Sciences, formerly Splash Beverage, Achieves - GlobeNewswire
Endovia's potential cannabinoid treatment for dogs with cancer pain enters FDA process - Stock Titan
EDVA Stock Quote Price and Forecast - CNN
Endovia Health Sciences, Inc. Balance Sheet – AMEX:EDVA - TradingView
Discontinued operations of Endovia Health Sciences, Inc. – AMEX:EDVA - TradingView
Endovia Health Sciences, Inc. Financial Statements – AMEX:EDVA - TradingView
EDVA Stock Price and Chart — AMEX:EDVA - TradingView
Splash Beverage Group to Become Endovia Health Sciences; New NYSE American Ticker “EDVA” Effective Monday - Yahoo Finance
Splash Beverage Group to Become Endovia Health Sciences; New NYSE American Ticker “EDVA” Effective Monday - GlobeNewswire
Splash Beverage Reports Second Quarter 2026 Results and - GlobeNewswire
Splash Beverage Group Reports Q2 2026 Results and Advances Transformation to Endovia Health Sciences - Quiver Quantitative
Splash Beverage shifts from alcoholic drinks to cannabinoid medicines for people and pets - stocktitan.net
Splash Beverage to rebrand as Endovia Health Sciences By Investing.com - Investing.com UK
Splash Beverage Group to Rebrand as Endovia Health Sciences - GlobeNewswire
Splash Beverage will officially become Endovia Health Sciences on August 21 (SBEV:NYSE) - Seeking Alpha
Splash Beverage to rebrand as Endovia Health Sciences - Investing.com
Splash Beverage Group to Rebrand as Endovia Health Sciences - Yahoo Finance UK
Splash Beverage to Rebrand as Endovia Health Sciences - Yahoo Finance
Splash Beverage plans shift from beverage business to cannabinoid health sciences - Stock Titan
Splash Beverage Group Announces Significant Balance Sheet - GlobeNewswire
Splash Beverage Group Receives NYSE American Acceptance of - GlobeNewswire
SBEV Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Endovia Health Sciences, Inc. (EDVA) 財務データ
Endovia Health Sciences, Inc. (EDVA) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
1.35%
大文字化:
|
ボリューム (24 時間):